ArchiveArchive
social

Hundreds of parents using Facebook to raise concerns over dangerous side effects of children’s Ibuprofen

The world’s biggest social media platform is being used as a gigantic virtual megaphone by hundreds of concerned parents who are reporting serious side effects from giving their child a medicine, after one mother’s Facebook safety warning.

As reported by the UK’s Daily Mail, Alison Smith took to the social media site to voice concerns after her four-month-old son Jensen lost consciousness following a 2.5 ml dose of Galhparm’s Junior Ibuprofen.

The Daily Mail reported that medical staff spent 45 minutes fighting to help Jensen regain consciousness.

After she reported the incident to retailer Tesco, where she had purchased the medication, store personnel took immediate action, removing the products from shelves in order to have them tested. However, personnel determined that the product was safe, and as such, it is now back on store shelves.

But, over the next couple of weeks, officials with Britain’s official regulatory agency said that they were contacted more than a half-dozen times over a single weekend about the product. And, they added that they are still receiving reports daily, so the actual number of complaints could be far higher.

“As of [recently], we have received seven reports over the weekend of Galpharm Junior Ibuprofen Suspension use associated with a burning or tingling sensation and we are now following these up as a matter of priority,” said a spokesman for the Medicines and Healthcare Products Regulatory Agency, the Daily Mail reported.

What do you mean, there is nothing wrong?

The spokesman went on to say that parents who are using the product currently have no cause for concern, because there is no proof at this time that the product on the market in the UK is unsafe.

“Anyone who has any questions or concerns should speak to a healthcare professional,” the spokesman – who was not identified in the report – said, adding that anyone who believes their child may have been harmed by the product or otherwise suffered an unintended consequence should contact the agency.

The spokesman went on to add additional boilerplate information to his response, including the fact that just because an agency is getting reports about harmful side effects of a medication, is “not necessarily proof of a side effect occurring.” (What?) Only a “suspicion” by the person making the report that something could be wrong.

So you see, it seems as though government agencies all over the world are the same as those in the United States – inhabited by unaccountable bureaucrats who live, breathe and die bureaucracy.

As for Smith, her post was shared over 27,000 times, with many parents writing about similar experiences with the same medication.

The dosage that Jensen received – 2.5 ml – was the dose recommended on the product’s packaging, by the way.

Smith said she created her Facebook campaign as a way to inform other parents about the product and what it could do, after dozens of other mothers came forward to complain about it. She told the Daily Mail she’s been contacted by a large number of parents since she posted her incident on Facebook who told her that their kids have also had similar reactions to the ibuprofen product.

Full recovery after a very scary incident

“Jensen had been ill so we gave him the medicine,” she told the news site, adding that he would not take it voluntarily, so “we force-fed it to him.”

She said she then tasted some of the medicine, and “my mouth went completely numb,” noting that her partner, Adrian, saw a blister form on his tongue.

“At this point we thought, ‘we have just given our child 2.5ml of this, we need to do something,’” she said. So, as the boy began drifting off to sleep, they called for medical assistance.

Smith said that neither she nor any of her immediate family are allergic to ibuprofen. She said also that officials with Galpharm initially said that they had received no other complaints of similar reactions.

Good news, however: Little Jensen recovered completely, Smith told the paper.

Sources:

DailyMail.co.uk

Science.NaturalNews.com

Multiple-Prescription-Bottled-Drugs-Pills

Common heartburn medications are increasing the risk of strokes

Proton pump inhibitors or PPIs – a class of drugs commonly used to treat acid reflux and heartburn – may increase the risk of ischemic stroke, according to preliminary research presented at an American Heart Association conference in New Orleans earlier this month.

As reported by CNN, these drugs are among the most prescribed medicines in the United States and are widely available over the counter. Dr. Thomas Sehested, the study’s lead author and a researcher at the Danish Heart Foundation, said that PPIs have been associated with unhealthy vascular functions, including heart attacks, kidney disease, and dementia.

Given their increasing use in the general population, Dr. Thomas Sehested and his team were eager to investigate if PPIs also increase the risk of an ischemic stroke.

Overall stroke risk 21 percent higher with PPI use

According to the Centers for Disease Control and Prevention (CDC), 85 percent of strokes are ischemic strokes. An ischemic stroke occurs when a blood clot blocks the artery that supplies oxygen-rich blood to the brain.

For their study, the researchers analyzed the records of almost 245,000 Danish adults, average age 57, who underwent endoscopy to pinpoint the causes of their stomach pain or indigestion. During six years of follow-up, nearly 9,500 patients experienced a first-time ischemic stroke.

Dr. Sehested and colleagues assessed if the stroke occurred while patients were using one of four commonly prescribed PPIs –  omeprazole (Prilosec), pantoprazole (Protonix), lansoprazole (Prevacid) and esomeprazole (Nexium). Furthermore, they also looked at the records of people who used another class of acid-reducing medications known as H2 blockers, which include Pepcid and Zantac.

Overall, the patients who took PPIs faced a 21 percent increase in the risk of an ischemic stroke, compared with patients who did not receive any of the PPIs mentioned above. The researchers noted that there was little or no greater risk of stroke associated with H2 blockers or small doses of PPIs. However, they found that at the highest PPI dose, the stroke risk increased from 30 percent for lansoprazole (Prevacid) to a whopping 94 percent for pantoprazole (Protonix).

Study questions the safety of PPIs

Since the study is purely observational, the authors were unable to prove cause and effect between PPI use and increased stroke risk. Nonetheless, they believe that their findings, along with previous studies, suggest patients should be cautious about using PPIs, many of which are now available over the counter.

And not only should patients be more cautious, but doctors prescribing PPIs should also carefully consider whether their use is warranted and for how long.

“At one time, PPIs were thought to be safe, without major side effects,” Sehested said. “This study further questions the cardiovascular safety of these drugs.”

Furthermore, the team added that even though they did not find a clear link between H2 blockers and stroke, they could not say that this group of drugs would be better and safer than PPIs in the treatment of acid reflux or heartburn.

Are there safer alternatives?

According to medical professionals, the majority of people who suffer from heartburn or acid reflux could significantly reduce their discomfort by making a few lifestyle changes. These lifestyle changes include losing weight, quitting smoking, and cutting back on spicy and fatty foods while increasing the intake of fresh, organic foods.

“As a culture, we tend to want a pill to deal with our problems, when a lot of people could reduce their heartburn by eating smaller meals, drinking less alcohol or not smoking,” Dr. Michael Katz told CNN.

Sources:

Edition.CNN.com

News.Heart.org

CDC.gov

Edition.CNN.com